Effect of drugs used in different type of myocardial infarction (STEMI or NSTEMI) on mortality

By Vincze Z.   Brugos B.   Lőrincz I.   Paragh G.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 6, 2014-06 ,pp. : 445-447

Govi-Verlag

Access to resources Recommend Favorite

Assessment of Anti-Ischemic and Antianginal Effect at Trough Plasma Concentration and Safety of Trimetazidine MR 35mg in Patients with Stable Angina Pectoris: A Multicenter, Double-Blind, Placebo-Controlled Study

By Sellier P.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 361-369

Adis International

Access to resources Recommend Favorite

Increased myocardial infarction risk a class effect of NSAIDs

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Increased myocardial infarction risk a class effect of NSAIDs

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Azimilide reduced the incidence of atrial fibrillation (AF) but had no effect on mortality in patients with left ventricular dysfunction after recent myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite